Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00304317Phase 4Withdrawn
Phase 4, randomised, double-blind trial of celecoxib oral solution in ureteral calculus, sponsored by University of Minnesota. Primary endpoint: Decrease in narcotic usage at 48 hours. Planned start Mar 2006; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00304317.